ArticlePharmacology research & perspectives2018

Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.

Melanie Wannick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.